Details for New Drug Application (NDA): 022090
✉ Email this page to a colleague
The generic ingredient in EOVIST is gadoxetate disodium. One supplier is listed for this compound. Additional details are available on the gadoxetate disodium profile page.
Summary for 022090
Tradename: | EOVIST |
Applicant: | Bayer Hlthcare |
Ingredient: | gadoxetate disodium |
Patents: | 0 |
Pharmacology for NDA: 022090
Mechanism of Action | Magnetic Resonance Contrast Activity |
Suppliers and Packaging for NDA: 022090
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EOVIST | gadoxetate disodium | SOLUTION;INTRAVENOUS | 022090 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-320 | 50419-320-05 | 5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-05) / 10 mL in 1 VIAL, SINGLE-DOSE |
EOVIST | gadoxetate disodium | SOLUTION;INTRAVENOUS | 022090 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-320 | 50419-320-15 | 5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-15) / 15 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1.8143GM/10ML (181.43MG/ML) | ||||
Approval Date: | Jul 3, 2008 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 2.72145GM/15ML (181.43MG/ML) | ||||
Approval Date: | Feb 4, 2013 | TE: | RLD: | Yes |
Expired US Patents for NDA 022090
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | EOVIST | gadoxetate disodium | SOLUTION;INTRAVENOUS | 022090-001 | Jul 3, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | EOVIST | gadoxetate disodium | SOLUTION;INTRAVENOUS | 022090-002 | Feb 4, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | EOVIST | gadoxetate disodium | SOLUTION;INTRAVENOUS | 022090-001 | Jul 3, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription